BATM Advanced Communications Limited (LON:BVC) said it has received a €29mln (£26mln) order to deliver 1,000 critical care mechanical ventilators to a European government. The networking tech and medical lab specialist said it has received an upfront fee of €7.25mln and expects the remaining balance to be paid upon completion of the delivery in the second half of 2020.
Sativa Group PLC (LON:SATI) revealed it has signed a letter of intent that could lead to the CBD wellness and medicinal cannabis specialist being acquired by OTC, CSE and Frankfurt-quoted StillCanna Inc. Sativa said the would-be buyer is a leader in cannabinoid extraction and agriculture, focusing on the large-scale manufacturing of CBD in Europe. Sativa also announced that it has appointed Peterhouse Capital as its corporate adviser with immediate effect.
Faron Pharmaceuticals Oy (LON:FARN) (NASDAQFIRSTNORTH:FARON) said it has raised gross proceeds of £12.8mln (€14mln) before expenses by selling new shares in the company. The group said the placing, announced on Tuesday after the market close, was significantly oversubscribed and comprises the issue of 2,719,002 Nordic placing shares at the Nordic issue price of €4.00 per share (representing a discount of 7.6% to the closing price of €4.33 on April 21 on Nasdaq First North) and up to 780,998 UK placing shares at the equivalent UK issue price of 348p per share. Faron shares closed trade in London on Tuesday at 395p each.
Pembridge Resources PLC (LON:PERE) has hailed “encouraging” results from operations at its Minto mine in the first quarter of 2020. The firm said over the quarter the mine produced 6,975 wet metric tonnes of concentrate, compared to 7,167 tonnes in the fourth quarter of 2019, while it has also received US$18.7mln in concentrate payments from Japanese firm Sumitomo, up from US$7.1mln in the prior quarter.
Allergy Therapeutics PLC (LON:AGY) has welcomed the publication of an academic paper endorsing the approach it has taken in using adjuvant technology for allergy immunotherapies. The paper, “State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI)”, in the journal Allergy, was written by an independent taskforce of EAACI members and co-authored by the Paul-Ehrlich-Institut.
RM Secured Direct Lending PLC (LON:RMDL) has said the focus of its portfolio on real assets and businesses not linked to the economic cycle will enable it to weather the current coronavirus storm as it reported 2019 results. For the year ending December 31, 2019, the value of assets the group's rose to £119.5mln from £95.7mln as its portfolio performed well in more normal conditions but the corporate lending market has since been hit by the virus disruption. “Looking ahead to the rest of 2020, opportunities will arise. However, first and foremost will be the management of the existing portfolio", it said.
Highland Gold Mining Limited (LON:HGM) told investors it produced 63,482 ounces of gold, in line with guidance, for the three months ended March 31, 2020. The Russia-based miner saw an average realised gold price of US$1,593 per ounce during the quarter, and the company repeated its 2020 production guidance for 290,000 to 300,000 ounces of gold and gold equivalent.
Shield Therapeutics PLC (LON:STX) has appointed chief financial officer (CFO), Tim Watts as its new chief executive officer (CEO), replacing outgoing CEO and founder Carl Sterritt who has resigned with immediate effect. Prior to joining the pharma firm, Watts served as CFO of Oxford BioMedica plc (LON:OXB) preceded by 22 years at AstraZeneca PLC (LON:AZN).
NQ Minerals PLC (LON:NQMI) (OTCQB:NQMLF) has unveiled a significant expansion of resources at the Barnes Hill nickel project, as lower grade material is folded into estimates. The new resource now stands at 25mln tonnes, at 0.6% nickel and 0.05% cobalt, up from 14mln tonnes. Additionally, the group said, findings from metallurgical test work has supported a new flowsheet whRead More – Source